Pembrolizumab (anti-PD-1)

Tax included
Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody inhibiting the programmed cell death 1 (PD-1) receptor, used in cancer immunotherapy.
MedChemExpress 
HY-P9902A

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1
Application
Cancer-programmed cell death